Boston News: MIT Tackles Universal Basic Income, Negative Reviews, and More
Let’s visit some of the biggest news coming out of Boston business schools this week.
12-Year Study Looks at Effects of Universal Basic Income – MIT Sloan Newsroom
MIT Sloan School of Management associate professor Tavneet Suri, alongside nonprofit company GiveDirectly, will conduct a lengthy, 12-year study into the effects of the constant hot-button issue of universal basic income. UBI is a basic concept that an acting government will assist its citizens by distributing a recurring stipend, supplementing the loss of jobs to things like automation.
“Suri is conducting the research along with MIT professor Abhijit Banerjee, Princeton professor Alan Krueger, University of California San Diego professor Paul Niehaus, and GiveDirectly president Michael Faye. Overall, GiveDirectly expects to transfer $25 million to more than 21,000 people (not including the control group), 5,000 of whom will receive cash transfers for 12 years. The money comes with no strings attached.”
Read more about the extensive MIT UBI study here.
The Costs and Benefits to Responding to Negative Online Reviews – BU.edu
When BU Questrom marketing professor Georgios Zervas and USC’s Davide Proserpio looked into thousands of TripAdvisor reviews, they found a fairly surprising turn: hotel managers that actively engaged with reviewers, positive or negative, may have actually helped their overall ratings. Zervas notes that it actually diminished the number of negative reviews because users were more wary when they saw hotel staff members participating in a conversation.
However, the two found that the reversal cause of this interaction was that negative reviews who did leave reviews, after engaging with the hotel staff, tended to leave longer reviews—which often made the negative details much more elaborated and personal. Zervas notes this is still probably good overall, saying, “The remaining negative reviews are detailed and contain constructive feedback that [hotel management] can act upon.”
BU professor Georgios Zervas and USC’s Davide Proserpio found uniquely beneficial ways companies can utilize review sites like TripAdvisor.
Read more about BU Questrom’s study on TripAdvisor here.
What Could Amazon’s Approach to Health Care Look Like? – HBR
The Amazon, Berkshire Hathaway, and JP Morgan Chase venture to disrupt the healthcare industry led to a minor panic for other healthcare shareholders, but its potential impact is still fairly uncertain. HBR writer Robert S. Huckman and admitted Amazon shareholder recently explored the potential positive impacts, including simplifying a very complex U.S. healthcare prescription service industry, “simplifying data capture,” and the repeated effort from Amazon to improve its services to regular customers.
On the latter reason, Huckman explains, “Amazon has an internal challenge — managing the health and health spending of its employees — that is shared by many other companies. Yet Amazon likely does not have a full “solution” in mind just yet. Rather, it has ideas and hypotheses to test. By creating a space in which those ideas can be tested, Amazon may be able to play a key role in allocating resources to solutions that show themselves, over time, to be promising.”
You can read more about Huckman’s outlook for Amazon healthcare here.
Stay up to date with all news from the Boston metro, as well as our MetroMBA Boston twitter feed, today.
Northeastern Professors Talk Dangers of Aetna-CVS Mega Merger
A recent multi-billion dollar mega-merger between health insurance company Aetna and popular medical dispensary chain CVS Heath has certainly raised some eyebrows, of which include several healthcare experts at Northeastern University and the D’Amore-McKim School of Business.
How An MBA Degree Can Land You a Job at Pfizer
MBA grads looking to make headway in an ever-expanding field with massive growth potential should look no further than healthcare and pharmaceuticals. There’s a reason more and more business school graduates have begun to pursue pharma over more tried-and-true post-MBA paths like real estate, consulting, and finance: the pharma industry offers a myriad of opportunities. There’s an almost inexhaustible supply of interesting problems to solve while earning boast-worthy salaries.
When it comes to major industry players, Pfizer is one of the undisputed global pharmaceutical leaders. Many of its products have burrowed their way into popular consciousness—both figuratively and literally. Lipitor, Viagra, Zoloft, Xanax, Advil, ChapStick, Preparation H, and Robitussin are iconic brands unto themselves.
Below, we’ll take a deeper look into exactly how MBAs can gain a foothold at Pfizer.
Why Do MBAs Love Pfizer?
Pfizer’s name brand recognition just so happens to correlate with a stellar internal reputation among employees, both past and present. Forbes, Fortune, LinkedIn, CareerBliss all consistently rank Pfizer as one of the happiest, most employee-centric, and/or most in-demand employers in the American pharma space.
In an interview with the Stevens Institute of Technology blog, Pfizer Senior QA Manager Bill Mestrandrea, a Stevens MBA alum, spoke of the deep camaraderie that he has with his fellow MBAs at Pfizer, comparing it to a “band of brothers.”
He elaborates: “We’re all in it together. I’ve met people from other departments who my work influences, and they’ve influenced my work as well. It gave me a better understanding of the network within Pfizer, and how it all comes together to form one company, always working in support of our patients.”
An anonymous former Pfizer employee took to Glassdoor to extol the company’s virtues: “If you can keep up with the fast pace and are not overly sensitive, Pfizer is a great to work. Everyday is an adventure and the benefits are excellent.” An anonymous Technical Specialist in the New York branch lauded Pfizer’s “great gym, clinic, cafeteria, and day care” in a Forbes profile.
Payscale reports that MBAs earn an average starting salary of around $121,000. Pfizer prides itself on a competitive compensation and benefits package that rewards employees “based on the contributions they make to [the] business.”
The company offers a number of in-house health and wellness programs, including health and disability insurance, medical screening, free or reduced-cost vaccinations, discounts on Pfizer products, and nutrition and fitness counseling. As part of the benefits package, Pfizer also offers access to colleague-directed retirement funds, company contributions to retirement financial vehicles, life insurance, and financial planning education.
Working at Pfizer
If there’s a common thread that runs through day-to-day life for all MBA grads at Pfizer, no matter their function, it’s that they’re all expected to move quickly and keep up with the constant demand. Pfizer is sympathetic and has sought out solutions to help acclimate first-year MBAs—namely, its Summer Associate Program, which has placed alum in full-time roles for the past 15 years.
Pfizer’s 10-12 week Summer Associate Program recruits and provides “first-year MBA students from top-ranked business schools … with a variety of unique experiences that will serve to develop and broaden critical skill sets and competencies as they progress their development towards leadership roles within Pfizer.”
Students are assigned challenging projects within Consumer Marketing, Corporate Audit, Corporate Finance, Global Procurement, Pfizer Consulting & Execution, and Pharmaceutical Marketing. By the end, Summer Associates “gain a wealth of valuable industry knowledge, networking opportunities, and life experiences.”
According to Pfizer, “MBA Summer Associates receive an industry competitive salary, housing support options and the prospect of conversion to a full-time opportunity upon the completion of their MBA degree.”
Jane Scholl (Columbia Business School ’12), whose healthcare resume stemmed from a desire to “improve the lives of others,” discussed the way her 2012 internship led to a position with the Marketing Rotational Program the following year:
“Though I only spent three months with Pfizer during the summer, I was treated as a valued member of the team rather than an intern. I was encouraged to share my thoughts and ideas even if they differed from those of other colleagues. I worked on meaningful projects that contributed to the business, and some of my recommendations were implemented before the end of the summer.”
Oindrila Sardar (Chicago Booth ’11), a Senior Manager at Pfizer’s Established Products Marketing Platform, discussed the relationship she had with the rotation managers during her Summer Associate internship:
“My rotation managers have played a critical role in my development with weekly one-on-one meetings and their insightful project guidance. They have been receptive to my interests and have matched them with meaningful assignments Throughout my rotations I have worked with cross-functional colleagues from many areas of the company which has helped me further understand Pfizer and its structure. I have been surprised by the high level of trust and responsibility given from the very beginning.”
Landing a Job at Pfizer
It’s pretty straightforward: Pfizer’s Summer Associate Internship is a surefire way for MBAs to get hired. In fact, 16 out of its recent 25 summer associates were extended full-time offers. That said, there’s plenty of recruitment that takes place outside the sacred intern space.
In the fall, Pfizer aggressively targets top MBA programs, particularly in the Mid-Atlantic and Northeast close to its New York HQ. The company is interested in drawing from a pool of diverse and competitive first-year applicants, especially those with a taste for finance, marketing, global supply, and general management. Although previous pharma experience will make your application more competitive, Pfizer is equally interested in applicants with compelling reasons for a career change.
Interviews begin in January and run until March. Pfizer sometimes conducts group interview sessions in which four or five applicants discuss issues with staff members. This process is designed to understand which folks will make a meaningful contribution to a Pfizer culture with many distinct and occasionally contentious points-of-view.
Mays and Humana Partner for Healthcare Analytics Competition
The Texas A&M University – Mays Business School will serve as host for the university’s first-ever healthcare analytics case competition, partnering with Humana Inc. to showcase student’s analytic ability.
Rotman Launching New MBA Program in Healthcare and Life Sciences
The Rotman School of Management at the University of Toronto will begin offering a new Global Executive MBA program in healthcare and the life sciences.
The Toronto-based university created the 18-month program to keep up with the industry’s fast-changing ways, according to a recent press release. Rotman wants to create leaders in the sector by teaching them the management skills and technical skills necessary to succeed in the healthcare and life sciences field.
While this MBA is the school’s latest health-based degree, it’s certainly not the school’s first. MBA candidates already have the option to major in Health Sector Management. This program is more geared toward healthcare delivery systems and the pharmaceutical and biotech industries.
The new MBA, however, will begin this semester, breaking up into five portions. Three will take place in Toronto, but the other two will fall elsewhere—in San Francisco and Singapore. Students will get a front-row seat to how the healthcare industry operates on a global scale. Individuals from life science firms, service delivery organizations, and global agencies are encouraged to apply for the program. It’s best suited for those who want to build their career.
“The program will focus on the most effective ways of organizing industries, whether in the public sector or the private sector to deliver the best healthcare and to make it more affordable,” says Brian R. Golden, Vice Dean of MBA Programs, in the press release.
The program will work with the school’s Centre for Health Sector Strategy, which Golden leads, to build upon its offerings on the topic. The Centre, according to Rotman, is “Canada’s leading academic provider of healthcare executive programs.” An additional plus? The city’s medical discovery district is not far at all. Students will have quick and easy access to innovations as they see fit.
“The health and life sciences sector is the most important industry in the world,” said William Mitchell, a Co-Academic Director of the Program, added. “Globally it has a huge impact on economic development and a huge impact on human life. Our new program will teach general management and leadership skills, with direct application to people working in life sciences and healthcare.”
Northeastern Professor Talks Obamacare’s Precarious Future
D’Amore-McKim Professor Timothy Hoff, a health policy and healthcare systems expert, recently discussed the precarious situation of the Affordable Care Act (ACA) within the current healthcare landscape.
